What does DR. JAN VERCRUYSSE, anesthesie do?

DR. JAN VERCRUYSSE, anesthesie is a property company in Brugge. Private Limited, started on 23 December 2010, 1 establishment.

What is the address of DR. JAN VERCRUYSSE, anesthesie?

The registered office of DR. JAN VERCRUYSSE, anesthesie is located at Rombout de Dopperestraat 3, 8200 Brugge.

Is DR. JAN VERCRUYSSE, anesthesie still active?

Yes. According to the CBE (3 October 2026) DR. JAN VERCRUYSSE, anesthesie is active, legal situation “Normale toestand”, started on 23 December 2010.

Is DR. JAN VERCRUYSSE, anesthesie registered on Peppol?

No, DR. JAN VERCRUYSSE, anesthesie is currently not registered on the Peppol network.

What is the enterprise number of DR. JAN VERCRUYSSE, anesthesie?

The enterprise number of DR. JAN VERCRUYSSE, anesthesie is BE0832388969.

When was DR. JAN VERCRUYSSE, anesthesie founded?

DR. JAN VERCRUYSSE, anesthesie was founded on 23 December 2010.

Who are the directors of DR. JAN VERCRUYSSE, anesthesie?

According to the 2025 annual accounts, the directors of DR. JAN VERCRUYSSE, anesthesie are: JAN VERCRUYSSE .

Is DR. JAN VERCRUYSSE, anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JAN VERCRUYSSE, anesthesie make in 2025?

DR. JAN VERCRUYSSE, anesthesie posted a profit after taxes of € 233,613 in financial year 2025.

What is the revenue of DR. JAN VERCRUYSSE, anesthesie?

As a small company, DR. JAN VERCRUYSSE, anesthesie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 412,488.

DR. JAN VERCRUYSSE, anesthesie (Private Limited) - Brugge

Dossier DR. JAN VERCRUYSSE, anesthesie, printed on 3 October 2026 from databakkes.be/en/0832388969/dr-jan-vercruysse-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. JAN VERCRUYSSE, anesthesie from Brugge, company number BE0832388969, closed financial year 2025 with a result of € 233,613 after tax. For that financial year DR. JAN VERCRUYSSE, anesthesie recorded a gross margin of € 412,488 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 153,953 to € 233,613. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 6, 2026.

What it is worth Healthy

€ 1.7 million

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 233,613

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 121,074

▲ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 300,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 43,152

▲ 197% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 335,945

▼ 18% vs 2024

€ 88,639 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 48,916

▲ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 415,612 Gross margin 2022: € 415,612 First fiscal year in the series	€ 377,511 Gross margin 2023: € 377,511 ▼ 9% vs 2022 (€ 415,612) Unfavourable step	€ 375,224 Gross margin 2024: € 375,224 ▼ 1% vs 2023 (€ 377,511) Unfavourable step	€ 412,488 Gross margin 2025: € 412,488 ▲ 10% vs 2024 (€ 375,224) Favourable step	▲ 10%
Profit after taxes	€ 201,176 Profit after taxes 2022: € 201,176 First fiscal year in the series	€ 178,888 Profit after taxes 2023: € 178,888 ▼ 11% vs 2022 (€ 201,176) Unfavourable step	€ 153,953 Profit after taxes 2024: € 153,953 ▼ 14% vs 2023 (€ 178,888) Unfavourable step	€ 233,613 Profit after taxes 2025: € 233,613 ▲ 52% vs 2024 (€ 153,953) Favourable step	▲ 52%
Equity	€ 1,479,244 Equity 2022: € 1,479,244 First fiscal year in the series	€ 1,658,132 Equity 2023: € 1,658,132 ▲ 12% vs 2022 (€ 1,479,244) Favourable step	€ 1,812,085 Equity 2024: € 1,812,085 ▲ 9% vs 2023 (€ 1,658,132) Favourable step	€ 1,745,698 Equity 2025: € 1,745,698 ▼ 4% vs 2024 (€ 1,812,085) Unfavourable step	▼ 4%
Total debts	€ 1,528,300 Total debts 2022: € 1,528,300 First fiscal year in the series	€ 1,283,815 Total debts 2023: € 1,283,815 ▼ 16% vs 2022 (€ 1,528,300) Favourable step	€ 1,071,579 Total debts 2024: € 1,071,579 ▼ 17% vs 2023 (€ 1,283,815) Favourable step	€ 1,176,034 Total debts 2025: € 1,176,034 ▲ 10% vs 2024 (€ 1,071,579) Unfavourable step	▲ 10%
Cash	€ 62,073 Cash 2022: € 62,073 First fiscal year in the series	€ 75,933 Cash 2023: € 75,933 ▲ 22% vs 2022 (€ 62,073) Favourable step	€ 64,873 Cash 2024: € 64,873 ▼ 15% vs 2023 (€ 75,933) Unfavourable step	€ 121,074 Cash 2025: € 121,074 ▲ 87% vs 2024 (€ 64,873) Favourable step	▲ 87%
Land & buildings	€ 2,741,693 Land & buildings 2022: € 2,741,693 First fiscal year in the series	€ 2,673,582 Land & buildings 2023: € 2,673,582 ▼ 2% vs 2022 (€ 2,741,693) Unchanged	€ 2,626,606 Land & buildings 2024: € 2,626,606 ▼ 2% vs 2023 (€ 2,673,582) Unchanged	€ 2,557,426 Land & buildings 2025: € 2,557,426 ▼ 3% vs 2024 (€ 2,626,606) Unchanged	▼ 3%
Retained profit	€ 1,309,244 Retained profit 2022: € 1,309,244 First fiscal year in the series	€ 1,488,132 Retained profit 2023: € 1,488,132 ▲ 14% vs 2022 (€ 1,309,244) Favourable step	€ 1,642,085 Retained profit 2024: € 1,642,085 ▲ 10% vs 2023 (€ 1,488,132) Favourable step	€ 1,575,698 Retained profit 2025: € 1,575,698 ▼ 4% vs 2024 (€ 1,642,085) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 300,000 Dividend 2025: € 300,000 Unchanged (€ 0) Unchanged
Bank debt	€ 785,621 Bank debt 2022: € 785,621 First fiscal year in the series	€ 569,783 Bank debt 2023: € 569,783 ▼ 27% vs 2022 (€ 785,621) Favourable step	€ 409,617 Bank debt 2024: € 409,617 ▼ 28% vs 2023 (€ 569,783) Favourable step	€ 335,945 Bank debt 2025: € 335,945 ▼ 18% vs 2024 (€ 409,617) Favourable step	▼ 18%
Balance sheet total	€ 3,007,544 Balance sheet total 2022: € 3,007,544 First fiscal year in the series	€ 2,941,947 Balance sheet total 2023: € 2,941,947 ▼ 2% vs 2022 (€ 3,007,544) Unchanged	€ 2,883,663 Balance sheet total 2024: € 2,883,663 ▼ 2% vs 2023 (€ 2,941,947) Unchanged	€ 2,921,732 Balance sheet total 2025: € 2,921,732 ▲ 1% vs 2024 (€ 2,883,663) Unchanged	▲ 1%

Key figures of DR. JAN VERCRUYSSE, anesthesie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. JAN VERCRUYSSE, anesthesie?

What happened at DR. JAN VERCRUYSSE, anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 6, 2026 New annual accounts for financial year 2025: profit of € 233,613 (▲ 52% vs 2024). filed late Source: NBB ↗
Dec 23, 2010 New establishment in Brugge. KBO
Dec 23, 2010 Start of the company according to the CBE. KBO

In short

From € 201,176 profit in 2022 to € 233,613 profit in 2025.

Paid € 271,313 in corporate taxes since 2022.

Best year ever: 2025, with € 233,613 profit.

Paid out € 300,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. JAN VERCRUYSSE, anesthesie? We notify you, reason included.

Follow DR. JAN VERCRUYSSE, anesthesie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JAN VERCRUYSSE

DR. JAN VERCRUYSSE, anesthesie

Behind DR. JAN VERCRUYSSE, anesthesie is JAN VERCRUYSSE .

See the full network in the app

Directors

According to the 2025 annual accounts

JAN VERCRUYSSE

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rombout de Dopperestraat 3

8200 Brugge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0832.388.969
VAT number: BE 0832.388.969
Registered office: Rombout de Dopperestraat 3, 8200 Brugge
Names & denominations: DR. JAN VERCRUYSSE, anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 December 2010
Peppol: Not registered
Activities · NACE: Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗